We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
Oatly Group
OTLY
$356M
| $1K | ﹤0.01% |
8
+1
| +14% | +$132 |
2021 Q4
1 quarter
|
|
2802
Otter Tail
OTTR
$3.76B
| $1K | ﹤0.01% |
12
-350
| -97% | -$22K |
2016 Q4
21 quarters
|
|
2803
Pacific Biosciences
PACB
$609M
| $1K | ﹤0.01% |
59
-44
| -43% | -$507 |
2021 Q1
4 quarters
|
|
2804
abrdn Physical Palladium Shares ETF
PALL
$601M
| $1K | ﹤0.01% |
25
| – | – |
2021 Q2
3 quarters
|
|
2805
Pembina Pipeline
PBA
$28B
| $1K | ﹤0.01% |
19
| – | – |
2020 Q4
5 quarters
|
|
2806
PDF Solutions
PDFS
$1.74B
| $1K | ﹤0.01% |
50
| – | – |
2018 Q4
13 quarters
|
|
2807
PennyMac Financial
PFSI
$3.18B
| $1K | ﹤0.01% |
27
+19
| +238% | +$1.15K |
2021 Q4
1 quarter
|
|
2808
Phathom Pharmaceuticals
PHAT
$607M
| $1K | ﹤0.01% |
80
+8
| +11% | +$129 |
2021 Q4
1 quarter
|
|
2809
Park Aerospace
PKE
$571M
| $1K | ﹤0.01% |
82
+2
| +3% | +$27 |
2021 Q4
1 quarter
|
|
2810
Playboy Inc
PLBY
$127M
| $1K | ﹤0.01% |
+79
| New | +$1.33K |
2022 Q1
0 quarters
|
|
|
PLYM
2811
DELISTED
Plymouth Industrial REIT
PLYM
| $1K | ﹤0.01% |
+21
| New | +$579 |
2022 Q1
0 quarters
|
|
2812
PRA Group
PRAA
$751M
| $1K | ﹤0.01% |
18
| – | – |
2016 Q4
21 quarters
|
|
2813
Primoris Services
PRIM
$3.97B
| $1K | ﹤0.01% |
31
| – | – |
2021 Q1
4 quarters
|
|
2814
Purple Innovation
PRPL
$9.9M
| $1K | ﹤0.01% |
+7
| New | +$1.38K |
2022 Q1
0 quarters
|
|
2815
CarParts.com
PRTS
$61.3M
| $1K | ﹤0.01% |
8
+2
| +33% | +$172 |
2020 Q4
5 quarters
|
|
2816
Parsons
PSN
$4.71B
| $1K | ﹤0.01% |
18
-29
| -62% | -$988 |
2021 Q3
2 quarters
|
|
2817
Quanterix
QTRX
$145M
| $1K | ﹤0.01% |
+33
| New | +$1.01K |
2022 Q1
0 quarters
|
|
2818
DELISTED
Redfin
RDFN
| $1K | ﹤0.01% |
41
-501
| -92% | -$12.9K |
2020 Q2
7 quarters
|
|
2819
Transocean
RIG
$6.15B
| $1K | ﹤0.01% |
200
| – | – |
2019 Q1
12 quarters
|
|
2820
Rigel Pharmaceuticals
RIGL
$883M
| $1K | ﹤0.01% |
31
+20
| +182% | +$541 |
2021 Q4
1 quarter
|
|
2821
DELISTED
RE/MAX Holdings
RMAX
| $1K | ﹤0.01% |
39
| – | – |
2020 Q1
8 quarters
|
|
2822
The RMR Group
RMR
$319M
| $1K | ﹤0.01% |
40
-40
| -50% | -$1.25K |
2016 Q4
21 quarters
|
|
2823
Renasant Corp
RNST
$3.64B
| $1K | ﹤0.01% |
30
-61
| -67% | -$2.23K |
2020 Q4
5 quarters
|
|
2824
Stepan Co
SCL
$1.41B
| $1K | ﹤0.01% |
14
-17
| -55% | -$1.84K |
2021 Q1
4 quarters
|
|
2825
DELISTED
Steelcase
SCS
| $1K | ﹤0.01% |
48
-23
| -32% | -$278 |
2021 Q1
4 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.